CytomX reports ADC data in late-line colorectal cancer; FDA OKs Cosentyx label expansion
CytomX reports ADC data in late-line colorectal cancer; FDA OKs Cosentyx label expansion
CytomX reports ADC data in late-line colorectal cancer; FDA OKs Cosentyx label expansion
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.